Literature DB >> 16100356

Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.

J Gore, R Silver.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16100356      PMCID： PMC1755633          DOI： 10.1136/ard.2004.034488

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  20 in total

Review 1.  Targeted therapy for systemic sclerosis: how close are we?

Authors:  Manuel Ramos-Casals; Vicent Fonollosa-Pla; Pilar Brito-Zerón; Antoni Sisó-Almirall
Journal:  Nat Rev Rheumatol       Date:  2010-04-13       Impact factor: 20.543

2.  Raynaud's phenomenon.

Authors:  Ariane Herrick
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-04

Review 3.  Recent advances in the treatment of systemic sclerosis.

Authors:  Vasiliki Kalliopi K Bournia; Panayiotis G Vlachoyiannopoulos; Carlo Selmi; Haralampos M Moutsopoulos; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

4.  Tadalafil therapy and severe chronic foot wound resolution.

Authors:  Claire Davenport; Andrew Dubin
Journal:  Int Wound J       Date:  2015-02-03       Impact factor: 3.315

5.  [Primary and secondary Raynaud's phenomenon].

Authors:  J H W Distler
Journal:  Z Rheumatol       Date:  2008-05       Impact factor: 1.372

6.  Oral sildenafil increases skin hyperaemia induced by iontophoresis of sodium nitroprusside in healthy volunteers.

Authors:  S Blaise; M Hellmann; M Roustit; S Isnard; J L Cracowski
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 7.  Old medications and new targeted therapies in systemic sclerosis.

Authors:  Vivek Nagaraja; Christopher P Denton; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2014-07-26       Impact factor: 7.580

8.  Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study.

Authors:  Kellen L Meadows; Christel Rushing; Wanda Honeycutt; Kenneth Latta; Leigh Howard; Christy A Arrowood; Donna Niedzwiecki; Herbert I Hurwitz
Journal:  Support Care Cancer       Date:  2014-10-24       Impact factor: 3.603

9.  Phosphodiesterase inhibitors in vascular ischemia: A case report and review of their use in ischemic conditions.

Authors:  Wendy Ky Ng; Yishai Rosenblatt; Gerald B Brock; David B O'Gorman; Bing Siang Gan
Journal:  Can J Plast Surg       Date:  2010

Review 10.  Advances in the treatment of Raynaud's phenomenon.

Authors:  Terri L Levien
Journal:  Vasc Health Risk Manag       Date:  2010-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.